Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

November 29, 2017 Leave a comment 3,736 Views

Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Cosine

Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

Single-cell RNA-Seq analysis made easy

An easy, cost-effective, and scalable method to deplete human ribosomal RNA for RNA-Seq

WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data

Experimental approaches and computational workflows for systematic mapping and functional interpretation of RNA modifications

A single–cell type transcriptomics map of human tissues

Cell-analysis technique could combat tuberculosis

Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’